{"id":"https://openalex.org/W3124530398","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","title":"Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases.","display_name":"Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases.","publication_year":2021,"publication_date":"2021-01-20","ids":{"openalex":"https://openalex.org/W3124530398","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","mag":"3124530398"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2021.39.3_suppl.309","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038656790","display_name":"Thomas R. Jeffry Evans","orcid":"https://orcid.org/0000-0002-4175-914X","observed_orcids":["https://orcid.org/0000-0002-4175-914X"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T.R. Jeffry Evans","raw_affiliation_strings":["University of Glasgow, Beatson West of Scotland Cancer Center, Glasgow, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Glasgow, Beatson West of Scotland Cancer Center, Glasgow, United Kingdom;","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eric Van Cutsem","raw_affiliation_strings":["University Hospital Gasthuisberg and University of Leuven, Leuven, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Gasthuisberg and University of Leuven, Leuven, Belgium;","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060176567","display_name":"Hans Prenen","orcid":"https://orcid.org/0000-0001-8802-7352","observed_orcids":["https://orcid.org/0000-0001-8802-7352"]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Hans Prenen","raw_affiliation_strings":["University Hospital Antwerp (UZ Antwerp), Antwerp, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Antwerp (UZ Antwerp), Antwerp, Belgium;","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark R. Middleton","raw_affiliation_strings":["Churchill Hospital, Oxford, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Churchill Hospital, Oxford, United Kingdom;","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089670001","display_name":"Debashis Sarker","orcid":"https://orcid.org/0000-0003-4814-8429","observed_orcids":["https://orcid.org/0000-0003-4814-8429","https://orcid.org/0000-0001-6948-2974"]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debashis Sarker","raw_affiliation_strings":["King's College Hospital, Institute of Liver Studies, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College Hospital, Institute of Liver Studies, London, United Kingdom;","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060128316","display_name":"Karin Tunblad","orcid":"https://orcid.org/0009-0004-3816-2678","observed_orcids":["https://orcid.org/0009-0004-3816-2678"]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karin Tunblad","raw_affiliation_strings":["Medivir, Stockholm, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir, Stockholm, Sweden;","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111328214","display_name":"Fredrik G. Oberg","orcid":"https://orcid.org/0000-0003-3609-1197","observed_orcids":["https://orcid.org/0000-0003-3609-1197"]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Fredrik Oberg","raw_affiliation_strings":["Medivir, Stockholm, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir, Stockholm, Sweden;","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111414751","display_name":"Tom Morris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Tom Morris","raw_affiliation_strings":["Medivir, Stockholm, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir, Stockholm, Sweden;","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011316096","display_name":"Linda Basse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Linda Basse","raw_affiliation_strings":["Medivir AB, Huddinge, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, Huddinge, Sweden;","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033962986","display_name":"Elizabeth Ruth Plummer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Ruth Plummer","raw_affiliation_strings":["Northern Centre for Cancer Care, Newcastle-upon-Tyne, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Centre for Cancer Care, Newcastle-upon-Tyne, United Kingdom;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"3_suppl","first_page":"309","last_page":"309"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.3422999978065491,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.3422999978065491,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.25,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.18019999563694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/intrahepatic-cholangiocarcinoma","display_name":"intrahepatic cholangiocarcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8600000143051147},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7429999709129333},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7990000247955322},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6309999823570251},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6029999852180481},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.879551887512207},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7183049917221069},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7010453343391418},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6726992130279541},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5077227354049683},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5001344680786133},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4853864908218384},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4752350151538849},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4404577612876892},{"id":"https://openalex.org/C2992208098","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver function","level":2,"score":0.4266423285007477},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4200449585914612},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4135606586933136},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36183106899261475},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22617751359939575}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2021.39.3_suppl.309","doi":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.309","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3203535040","https://openalex.org/W2739745402","https://openalex.org/W2613783831","https://openalex.org/W7222963956","https://openalex.org/W2560393538","https://openalex.org/W4403685731","https://openalex.org/W3203724144","https://openalex.org/W2321383237","https://openalex.org/W3099100880","https://openalex.org/W4242609118"],"abstract_inverted_index":{"309":[0],"Background:":[1],"MIV-818":[2,88,173,350,357,375],"is":[3,12,37,111,122,126,137],"an":[4,93,112,359],"orally":[5],"administered":[6,91],"troxacitabine":[7],"(TRX)-based":[8],"nucleotide":[9,24],"prodrug.":[10],"It":[11],"highly":[13],"metabolized":[14],"by":[15],"human":[16],"hepatocytes,":[17],"directing":[18],"high":[19],"levels":[20],"of":[21,99,106,172,193,237,292,319,333,349,367,374],"the":[22,27,150,162,187,190,262,293,312,391],"chain-terminating":[23],"tri-phosphate":[25,36],"to":[26,32,45,138,148,160,185,248,301,308,324],"liver,":[28],"while":[29],"minimizing":[30],"exposure":[31],"other":[33],"organs.":[34],"The":[35,134,170,253],"incorporated":[38],"into":[39],"DNA":[40,46,50,335],"during":[41],"replication,":[42],"which":[43],"leads":[44],"double":[47],"strand":[48],"breaks,":[49],"damage":[51,336],"responses,":[52],"and":[53,121,141,174,179,189,283,303,362,381],"cytotoxicity.":[54],"Methods:":[55],"Patients":[56,244],"(pts),":[57],"\u226518":[58],"years,":[59],"ECOG":[60,200],"performance":[61,201],"status":[62,202],"<":[63],"1,":[64],"adequate":[65],"organ":[66],"function,":[67],"with":[68,97,215,232,344],"treatment-refractory":[69],"hepatocellular":[70],"carcinoma":[71],"(HCC),":[72],"intrahepatic":[73],"cholangiocarcinoma":[74],"(iCCA)":[75],"or":[76,131,205,221,346],"liver":[77,181,284,313,354,368],"metastases":[78],"(LM)":[79],"from":[80,224,384],"solid":[81,225],"tumors":[82,226],"were":[83,177,183,239,245,259,288,295],"enrolled.":[84],"In":[85],"phase":[86,145,154,242,320,385],"Ia,":[87,146],"monotherapy":[89],"was":[90,159,322],"in":[92,104,116,241,261,337,341,352],"intra-patient":[94],"dose-escalation":[95],"design":[96,120],"doses":[98],"3-70mg":[100],"for":[101,144,153],"3-5":[102],"days":[103],"cycles":[105],"21":[107],"days.":[108],"Phase":[109],"Ib":[110,321,386],"inter-patient":[113],"dose":[114,152,318],"escalation":[115],"a":[117,371],"3+3":[118],"cohort":[119],"currently":[123],"ongoing.":[124],"Treatment":[125],"given":[127],"until":[128],"disease":[129,310],"progression":[130],"unacceptable":[132],"toxicity.":[133],"primary":[135],"objective":[136,158],"assess":[139,186],"safety":[140,361,380],"tolerability":[142,363],"and,":[143],"also":[147,289],"establish":[149],"starting":[151],"Ib.":[155],"Key":[156],"secondary":[157],"evaluate":[161],"overall":[163],"response":[164],"rate":[165],"based":[166],"on":[167,376],"RECIST":[168],"v1.1.":[169],"pharmacokinetics":[171,188],"its":[175],"metabolites":[176],"evaluated,":[178],"on-treatment":[180],"biopsies":[182,330,369],"collected":[184],"pharmacodynamic":[191],"effects":[192],"MIV-818.":[194],"Results:":[195],"Nine":[196],"patients":[197],"(7M;":[198],"2F),":[199],"0":[203],"(n=3)":[204],"1":[206],"(n=6),":[207],"median":[208,233],"age":[209],"=":[210],"57":[211],"years":[212],"(range:":[213],"50-84)":[214],"HCC":[216],"(2":[217],"pts),":[218],"iCCA":[219],"(1)":[220],"LM":[222],"(6)":[223],"(mainly":[227],"GI":[228],"tract),":[229],"previously":[230],"treated":[231],"2":[234],"(1-5)":[235],"lines":[236],"therapy,":[238],"included":[240],"Ia.":[243],"dosed":[246],"up":[247],"60":[249],"mg":[250],"5":[251,327],"days/week.":[252,328],"most":[254],"common":[255],"treatment":[256],"related":[257],"AEs":[258,294],"those":[260],"hematological":[263],"system:":[264],"neutropenia":[265],"grade":[266],"(gr)":[267],"1-4,":[268],"neutropenic":[269],"sepsis":[270],"gr":[271,274,277,281,286],"4;":[272],"thrombocytopenia":[273],"1-2,":[275],"anemia":[276],"1-2.":[278],"Elevated":[279],"bilirubin":[280],"1-3":[282],"enzymes":[285],"3":[287],"reported.":[290],"Most":[291],"reversible.":[296],"Five":[297],"pts":[298,305],"discontinued":[299,306],"due":[300,307],"AE":[302],"4":[304],"progressive":[309],"outside":[311],"after":[314],"2-4":[315],"cycles.":[316],"Starting":[317],"determined":[323],"be":[325,388],"40mg":[326],"Tumor":[329],"showed":[331],"evidence":[332],"selective":[334,372],"tumor":[338],"tissue,":[339],"including":[340],"hypoxic":[342],"regions,":[343],"minimal":[345],"no":[347],"impact":[348],"observed":[351],"healthy":[353],"tissue.":[355],"Conclusions:":[356],"had":[358],"acceptable":[360],"profile.":[364],"Biomarker":[365],"data":[366,383],"demonstrated":[370],"effect":[373],"cancer":[377],"cells.":[378],"Updated":[379],"efficacy":[382],"will":[387],"presented":[389],"at":[390],"meeting.":[392],"(NCT03781934).":[393],"Clinical":[394],"trial":[395],"information:":[396],"2018-000995-14.":[397]},"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-02-01T00:00:00"}